Similar articles

• The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.

  Hendrix SL. Hendrix SL. J Am Osteopath Assoc. 2003 Feb;103(2 Suppl 2):S3-5. J Am Osteopath Assoc. 2003. PMID: 12625631 No abstract available.
• [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].

  Henriksson P. Henriksson P. Lakartidningen. 2002 Nov 21;99(47):4716-9. Lakartidningen. 2002. PMID: 12523045 Swedish. No abstract available.
• Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.

  [No authors listed] [No authors listed] Harv Womens Health Watch. 2002 Oct;10(2):2-4. Harv Womens Health Watch. 2002. PMID: 12393317 No abstract available.
• Be careful of what you wish for: putting the WHI Estrogen/Progestin and HERS II Trials in perspective.

  Randolph JF Jr; Women's Health Initiative Estrogen/Progestin and HERS II Trials. Randolph JF Jr, et al. Medscape Womens Health. 2002 Jul-Aug;7(4):7. Medscape Womens Health. 2002. PMID: 12466739 Review. No abstract available.
• Postmenopausal hormone replacement therapy in the light of the women's health initiative trial.

  van der Mooren MJ, Kenemans P. van der Mooren MJ, et al. Eur J Obstet Gynecol Reprod Biol. 2003 Apr 25;107(2):123-4. doi: 10.1016/s0301-2115(02)00413-x. Eur J Obstet Gynecol Reprod Biol. 2003. PMID: 12648855 Review. No abstract available.